Market Risers: Imperial Brands PLC, AstraZeneca plc, National Grid plc & UNILEVER/PAR VTG FPD 0.031111

Imperial Brands
[shareaholic app="share_buttons" id_name="post_below_content"]

The share price for Imperial Brands PLC company symbol: LON:IMB has climbed 1.56% or 42 points throughout the session so far. Market buyers have so far held a positive outlook during this period. Range high for the period so far is 2762 dipping to 2685. The total volume traded so far comes to 597,035 while the average shares exchanged is 2,683,974. A 52 week share price high is 3198.5 about 504.5 points difference from the previous days close and putting the 52 week low at 2298 a difference of some 396 points. Imperial Brands PLC now has a 20 moving average of 2681.05 with a 50 day simple moving average now at 2685.08. The market capitalisation currently stands at £25,740.62m at the time of this report. The share price is in Great British pence. Mcap is measured in GBP. This article was written with the last trade for Imperial Brands PLC being recorded at Friday, November 9, 2018 at 12:05:15 PM GMT with the stock price trading at 2736 GBX.

 

Shares of AstraZeneca plc with company EPIC: LON:AZN has moved up 1.08% or 66 points in today’s trading session so far. Market buyers have stayed positive throughout the trading session. Range high for the period so far is 6165 dipping to 6069. The total volume traded so far comes to 525,541 with the daily average at 2,506,213. The stock 52 week high is 6196 around 103 points in difference on the previous days close and a 52 week low being 4544.5 which is a difference of 1548.5 points. AstraZeneca plc now has a 20 SMA of 5912.1 and the 50 day simple moving average now at 5852.6. The market cap now stands at £77,795.59m at the time of this report. All share prices mentioned for this stock are traded in GBX. Mcap is measured in GBP. This article was written with the last trade for AstraZeneca plc being recorded at Friday, November 9, 2018 at 12:05:49 PM GMT with the stock price trading at 6159 GBX.

 

The stock price for National Grid plc company symbol: LON:NG has climbed 1.05% or 8.84 points throughout today’s trading session so far. Buyers have remained optimistic during the trading session. Range high for the period so far is 851.4 dipping to 839.7. The volume total for shares traded up to this point was 1,840,292 with the daily average number around 9,458,883. The 52 week high price for the shares is 930.1 which is 90.1 points different to the previous business close and a 52 week low sitting at 733 is a variance of 107 points. National Grid plc now has a 20 moving average of 836.57 and now its 50 day simple moving average now of 813.66. This puts the market capitalisation now at £28,668.01m at the time of this report. The share price is in Great British pence. Mcap is measured in GBP. This article was written with the last trade for National Grid plc being recorded at Friday, November 9, 2018 at 12:05:42 PM GMT with the stock price trading at 848.84 GBX.

 

The share price for UNILEVER/PAR VTG FPD 0.031111 ticker lookup code: LON:ULVR has climbed 1.24% or 50.5 points throughout today’s trading session so far. Buyers seem confident during the session. Range high for the period has seen 4151 meanwhile the session low reached 4083.5. The number of shares traded by this point in time totalled 757,479 with the daily average at 3,172,646. The 52 week high is 4503.66 which comes in at 426.66 points difference from the previous days close and the 52 week low at 3678.5 which is a variance of 398.5 points. UNILEVER/PAR VTG FPD 0.031111 now has a 20 simple moving average of 4134.43 and now its 50 day moving average now at 4201.29. Market capitalisation for the company is £119,172.48m at the time of this report. The currency for this stock is Great British pence.Market cap is measured in GBP. This article was written with the last trade for UNILEVER/PAR VTG FPD 0.031111 being recorded at Friday, November 9, 2018 at 12:05:34 PM GMT with the stock price trading at 4127.5 GBX.

Twitter
LinkedIn
Facebook
Email
Reddit
Telegram
WhatsApp
Pocket
Find more news, interviews, share price & company profile here for:
    AstraZeneca's Tagrisso gains EU approval for treating advanced NSCLC, showing significant efficacy in reducing disease progression in key trials.
    AstraZeneca's Imfinzi receives FDA approval for limited-stage small cell lung cancer, marking a significant breakthrough in extending patient survival.
    Imperial Brands PLC reports a robust 2024 with 4.6% revenue growth, significant gains in market share, and a 10.9% increase in adjusted earnings per share.

      Search

      Search